ArticleNature communications2023

Gain-of-function mutant p53 together with ERG proto-oncogene drive prostate cancer by beta-catenin activation and pyrimidine synthesis.

Donglin Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.